Market Capital
₹26,165 Cr.
P/E
41.99
Share Price
₹ 1537.95 -10.3 (-0.67%)
Quick View
₹ 1537.95 -10.3 (-0.67%)
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Company Timeline

Forensics
ROE
Net Profit Margin is responsible for ROE increase over last 10 years
Other Income
Other Income is not affecting ratios of the company
Pledge
Promoters have not pledged a significant portion of their holding
Working Capital
Working Capital of the company seems to be under control
Revenue Recognition
Company is converting accounting profit to cash
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Capex vs ROCE
ROCE of the company has increased over the last three years
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been selling the stock which is usually a good time to buy
Share price
Share price has increased over last 10 years but more due to rerating
Current vs Historic Valuation
Company is trading at a discount to 3yr historic valuations
Promoter Holding
Promoter has not sold any shares in the last 90 days
Debt
Company should not have issues servicing its debt
ROE
Latest
35.07%
3yr Average
40.98%
5yr Average
29.77%
Net Profit Margin
Latest
18.78%
3yr Average
27.57%
5yr Average
19.97%
ROCE
Latest
44.96%
3yr Average
36.75%
5yr Average
31.2%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Market Share
0% (as of Jul 22)
Anti - Diabetes - Market Share
5.97% (as of Jul 22)
Anti-Infectives - Market Share
1.14% (as of Nov 21)
Antineo Plastic - Market Share
13.90% (as of Mar 22)
Augmentin - Market Share
3.40% (as of Mar 22)
Betnesol - Market Share
5.80% (as of Mar 22)
Betnovate C - Market Share
6.10% (as of Mar 22)
Betnovate N - Market Share
0.64% (as of Nov 21)
Blood Related - Market Share
9.30% (as of Mar 22)
Calpol - Market Share
0.08% (as of Jul 22)
Cardiovascular - Market Share
5.60% (as of Mar 22)
Ceftum - Market Share
10.50% (as of Nov 21)
Dermatology - Market Share
5.20% (as of Mar 22)
Eltroxin - Market Share
11.80% (as of Nov 21)
Endocrinology - Market Share
0.09% (as of Jul 22)
Gastro-Intestinal - Market Share
0.24% (as of Nov 21)
Gynecology - Market Share
0.01% (as of May 20)
Neurological - Market Share
0.79% (as of Nov 21)
Ophthalmology - Market Share
3.25% (as of Nov 21)
Pain - Market Share
2.60% (as of Dec 22)
Pharmaceutical Sector - Market Share
2.23% (as of Nov 21)
Respiratory - Market Share
3% (as of Nov 21)
Stomatological - Market Share
2.80% (as of Mar 22)
Synflorix - Market Share
6.20% (as of Mar 22)
T Bact - Market Share
1.21% (as of Jan 20)
Urology - Market Share
24.13% (as of Jul 22)
Vaccines - Market Share
1.92% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
5.20% (as of Mar 19)
Zinetac - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Wise Break-Up - Domestic

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Acute vs Chronic

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Domestic Sales Growth - YoY (%)
    • Management Compensation as a % of Sales (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Augmentin
    Betnesol
    Calpol
    Company Filing
    Show Previous Years
    Discussions & Analysis